Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-screening Survey for Metabolic, Cardiovascular, Obesity, Mental Health, and Endocrine Trial Eligibility (DOVE-MET-COME-100)

NCT07106879 is registered in ClinicalTrials.gov with Clindove Research LLC as lead sponsor.

NCT NCT07106879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07106879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-screening Survey for Metabolic, Cardiovascular, Obesity, Mental Health, and Endocrine Trial Eligibility (DOVE-MET-COME-100)
Lead sponsor
Clindove Research LLC
Phase
Observational
Overall status
Recruiting
Start date
July 30, 2025
Completion date
December 1, 2030
Enrollment
7,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney disease (ckd), endocrine dysfunction, mental health disorders, metabolic syndrome, obesity, prediabetes, type 2 diabetes mellitus (t2dm)